Analysis of serum catalase activities in pancreatic diseases

Journal of Gastroenterology

Volumn 39, Issue 5, 2004, Pages 469-474

  Fukui, Masayo ^a,b   Kanoh, Makoto ^a   Takamatsu, Yasushi ^a   Arakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fukui Medical Clinic   (Japan)

Author keywords

Active oxygen species; Acute pancreatitis; Catalase; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

CATALASE;

ACUTE PANCREATITIS; ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTOANALYZER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HEALTH SERVICE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PANCREAS DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; APACHE; BIOLOGICAL MARKERS; CATALASE; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; SENSITIVITY AND SPECIFICITY;

EID: 3042662413     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1325-2     Document Type: Article

References (22)

1. Knaus WA, Zimmermam JE, Wagner DP, Draper EA. APACHE II: a severity of disease classification. Crit Care Med 1985;13:818-29.
2. Ohmann C, Hau T. Prognostic indices in peritonitis. Hepatogastroenterology 1997;44:937-46.
3. . Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor alpha. Cytokine 1991;3:12-6.
4. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-5.
5. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
6. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
7. Gross V, Andreesen R, Leser HG, Ceska M, Liehl E, Lausen M, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22:200-3.
8. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
9. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 1985;312:159-64.
10. Iwamura J, Tanaka H, Takeuchi M, Hosotsubo H. Quantitative analysis of catalase activity in human serum (in Japanese). J Med Technol 1991;35:1347-50.
11. Iwamura J, Hosono M, Iwamoto N, Somatomo K, Takeuti N. Quantitative analysis of catalase activity in human serum (second report) (in Japanese). J Med Technol 1993;37:87-90.
12. Ogawa M. The concept of SIRS and the proposal of a new classification of the severity of organ dysfunction. Surgery Frontier 1994;1:7-11.
13. Ogawa M, Hirota M, Hayakawa T, Matsuno M, Watanabe S, Ashimi H, et al. Nationwide survey of severe acute pancreatitis in Japan: annual research report by Division of Refractory Pancreatic Disorders, Study Group of Gastrointestinal Disorders (in Japanese). Ministry of Health and Welfare; 1998, p. 9-23.
14. 2 in inflammatory diseases. Clin Chem 1993;39:2453-9.
15. 2. Scand J Gastroenterol Suppl 1996;219:24-7.
16. 2 activation using an immunoassay for the free activation peptide DSGISPR. Ann Clin Biochem 1991;28:497-503.
17. Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, et al. Trypsinogen activation peptide assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8.
18. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MGT, Slavin J, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000;355:1955-60.
19. Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001;164:162-70.
20. Kitagawa M, Naruse S, Ishiguro H, Nakae Y, Kondo T, Hayakawa T, et al. Prediction of the severity and prognosis in the patients with acute pancreatitis using various scoring systems (in Japanese). J Jpn Pancreas Soc 1998;13:483-90.
21. Guice KS, Miller DE, Oldham KT, Townsend CM, Thompson JC. Superoxide dismutase and catalase: a possible role in established pancreatitis. Am J Surg 1986;151:163-9.
22. Chardavoyne R, Asher A, Bank S, Stein TA, Wise L. Role of reactive oxygen metabolites in cardiopulmonary changes of acute hemorrhagic pancreatitis. Dig Dis Sci 1989;34:1581-4.